Back
18
Day Range
$69.93
$72.05
52-Week Range
$61.78
$89.83
Volume
1,736,222
50D / 200D Avg
$80.00
/
$74.62
Prev Close
$69.96
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 36.6 | 14.0 |
| P/B | 1.7 | 2.4 |
| ROE % | 4.6 | 11.4 |
| Net Margin % | 9.2 | 10.1 |
| Rev Growth 5Y % | 8.8 | 7.0 |
| D/E | 0.3 | 0.5 |
Key Takeaways
Revenue grew 8.78% annually over 5 years — modest growth
ROE of 4.59% is below average
Debt/Equity of 0.34 — conservative balance sheet
Generating 433.70M in free cash flow
P/E of 36.56 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.72%
Growth
Revenue Growth (5Y)
8.78%
Revenue (1Y)5.06%
Earnings (1Y)-4.44%
FCF Growth (3Y)42.03%
Quality
Return on Equity
4.59%
ROIC4.65%
Net Margin9.16%
Op. Margin16.69%
Safety
Debt / Equity
0.34
Current Ratio1.89
Interest Coverage6.83
Valuation
P/E Ratio
36.56
P/B Ratio1.66
EV/EBITDA23.98
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.06% | Revenue Growth (3Y) | 6.72% |
| Earnings Growth (1Y) | -4.44% | Earnings Growth (3Y) | 12.89% |
| Revenue Growth (5Y) | 8.78% | Earnings Growth (5Y) | -40.27% |
| Profitability | |||
| Revenue (TTM) | 4.09B | Net Income (TTM) | 374.90M |
| ROE | 4.59% | ROA | 3.02% |
| Gross Margin | 60.67% | Operating Margin | 16.69% |
| Net Margin | 9.16% | Free Cash Flow (TTM) | 433.70M |
| ROIC | 4.65% | FCF Growth (3Y) | 42.03% |
| Safety | |||
| Debt / Equity | 0.34 | Current Ratio | 1.89 |
| Interest Coverage | 6.83 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 36.56 | P/B Ratio | 1.66 |
| P/S Ratio | 3.35 | PEG Ratio | -8.16 |
| EV/EBITDA | 23.98 | Dividend Yield | 0.00% |
| Market Cap | 13.70B | Enterprise Value | 16.38B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.09B | 3.90B | 3.59B | 3.31B | 2.92B |
| Net Income | 374.90M | 392.30M | 294.20M | 385.80M | 2.94B |
| EPS (Diluted) | 1.87 | 1.96 | 1.48 | 1.94 | 59.07 |
| Gross Profit | 2.48B | 2.60B | 2.36B | 2.14B | 1.96B |
| Operating Income | 682.90M | 705.70M | 533.10M | 507.60M | 505.80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.39B | 12.32B | 11.66B | 11.49B | 9.61B |
| Total Liabilities | 4.16B | 4.23B | 4.11B | 4.32B | 2.66B |
| Shareholders' Equity | 8.24B | 8.08B | 7.55B | 7.17B | 6.94B |
| Total Debt | 2.78B | 2.58B | 2.57B | 2.76B | 1.48B |
| Cash & Equivalents | 110.60M | 107.60M | 120.80M | 138.20M | 95.90M |
| Current Assets | 2.11B | 1.95B | 1.70B | 1.53B | 1.47B |
| Current Liabilities | 1.11B | 1.02B | 969.00M | 1.28B | 732.10M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#969 of 1018
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026